Picture of Stereotaxis logo

STXS Stereotaxis Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Stereotaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-10.7-18.3-20.7-24-21.6
Depreciation
Amortisation
Non-Cash Items9.9110.610.412.112
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.25-1.10.6122.5-5.62
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-2.95-8.41-9.14-8.5-13.7
Capital Expenditures-1.4-2.38-0.366-0.034-0.093
Purchase of Fixed Assets
Other Investing Cash Flow Items-19.720.10.108
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-1.4-22.119.80.074-0.093
Financing Cash Flow Items-0.893
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.5470.220.0810.29714.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.8-30.310.7-8.130.985